Publisher Future Science Group (FSG) has announced the release of the 10-Year Anniversary Special Focus Issue of award-winning, MEDLINE-indexed journal Regenerative Medicine entitled ‘Regenerative medicine: past, present and future’, which reflects on how the field has changed in the past 10 years.
The special issue takes a look at the past decade in regenerative medicine and provides an overview and perspectives on the progress being made in the field as a whole, as well as in a number of more specific areas including cellular therapy, genome editing, pluripotent stem cell research, ligament regenerative engineering, nanotechnology, immunogenicity and regenerative pharmacology. The issue also provides insight into major institutions involved in the field of regenerative medicine, describing their history, current work and plans for the future.
The Special Focus Issue has been guest edited by Robert Lanza (Astellas Institute for Regenerative Medicine, MA, USA), who serves as one of the journal’s Associate Editors. Lanza provided a scene-setting foreword for the issue where he looks back at the last decade in regenerative medicine and describes some of the incredible progress made in the field. He then goes on to provide an overview of the wide variety of work presented in the issue including reviews, perspectives and special reports, amongst others.
The special focus issue is available online at http://www.futuremedicine.com/toc/rme/11/8.
Regenerative Medicine is part of the internationally recognized Future Medicine portfolio and is supported by a multidisciplinary, international editorial board comprising leading researchers and opinion leaders from academia and industry, including Senior Editor Chris Mason (UCL, UK), and Associate Editors Phillipe Menasché (Hôpital Européen Georges Pompidou, FR), Gail Naughton (Histogen Inc., CA, USA) and the aforementioned Robert Lanza.
The journal is currently inviting submissions of original research, review and perspective pieces, as well as shorter pieces such as editorials and organisational profiles. Submissions are being accepted via the journal’s online submission site. Alternatively, authors are invited to direct any article proposals or general queries to the Commissioning Editor, Adam Price-Evans at a.price-evans@futuremedicine.com.
Brought to you by Scope e-Knowledge Center, a world-leading provider of metadata services, abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).
